{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:26:47Z","timestamp":1757618807847,"version":"3.44.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Major Scientific and Technological Projects for collaborative prevention and control of birth defects in Hunan Province","award":["Major Scientific and Technological Projects for collaborative prevention and control of birth defects in Hunan Province"],"award-info":[{"award-number":["Major Scientific and Technological Projects for collaborative prevention and control of birth defects in Hunan Province"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Idiopathic pulmonary arterial hypertension (IPAH), a rare and devastating pulmonary vascular disorder, is characterized by cellular proliferation and vascular remodeling. Although previous studies have underscored that ferroptosis, an iron-dependent cell death process, plays an important regulatory role in pulmonary artery hypertension, its role remains understudied. Gene expression profiles were downloaded from the Gene Expression Omnibus(GEO). Differentially expressed genes (DEGs) were screened using R software and intersected with a ferroptosis database (FerrDb V1) to identify ferroptosis-related DEGs. GO and KEGG analyses were performed to explore biological functions and potential pathways. LASSO and SVM-RFE algorithms were used to identify optimal gene biomarkers for IPAH. GSVA and GSEA were conducted to explore biological functions and potential pathways associated with these biomarkers. The CIBESORT software was employed to predict immune genes and functions. Of 237 ferroptosis-related genes (FRGs), 27 differentially expressed FRGs (DE-FRGs) showed significant differences between IPAH and normal samples in GSE48149, with 15 downregulated and 12 upregulated genes. Six DE-FRGs, including <jats:italic>KEAP1<\/jats:italic>, <jats:italic>TNFAIP3<\/jats:italic>, <jats:italic>MEG3<\/jats:italic>, <jats:italic>NFS1<\/jats:italic>, <jats:italic>PRDX1<\/jats:italic>, and <jats:italic>BEX1<\/jats:italic>, were identified as predictive diagnostic genes for IPAH. Among these DE-FRGs, <jats:italic>PRDX1<\/jats:italic> and <jats:italic>TNFAIP3<\/jats:italic> were the most promising diagnostic genes for IPAH and may play a corresponding role in IPAH by participating in the cell cycle, lysosomes, immune response, vascular smooth muscle contraction, and various diseases. CIBERSORT analysis revealed a positive correlation between neutrophils and <jats:italic>TNFAIP3<\/jats:italic>, whereas macrophages M0 exhibited a negative correlation with <jats:italic>PRDX1<\/jats:italic>. Through comprehensive bioinformatics analysis, we identified six differentially expressed ferroptosis-related genes (DE-FRGs)\u2014<jats:italic>KEAP1<\/jats:italic>, <jats:italic>TNFAIP3<\/jats:italic>, <jats:italic>MEG3<\/jats:italic>, <jats:italic>NFS1<\/jats:italic>, <jats:italic>PRDX1<\/jats:italic>, and <jats:italic>BEX1<\/jats:italic>\u2014in idiopathic pulmonary arterial hypertension (IPAH). Among these, <jats:italic>PRDX1<\/jats:italic> and <jats:italic>TNFAIP3<\/jats:italic>, which play key roles in IPAH pathogenesis, emerged as the most promising diagnostic biomarkers.<\/jats:p>","DOI":"10.1038\/s41598-025-11066-y","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T02:49:33Z","timestamp":1752288573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated bioinformatics identifies ferroptosis biomarkers and therapeutic targets in idiopathic pulmonary arterial hypertension"],"prefix":"10.1038","volume":"15","author":[{"given":"Yuhao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongshi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"key":"11066_CR1","doi-asserted-by":"crossref","unstructured":"Kasavi, C. Idiopathic Pulmonary Arterial Hypertension: Network-Based Integration of Multi-Omics Data Reveals New Molecular Signatures Candidate Drugs OMICS 27(7): 315\u2013326. (2023).","DOI":"10.1089\/omi.2023.0066"},{"issue":"1","key":"11066_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Galie","year":"2016","unstructured":"Galie, N. et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS): endorsed by: association for European paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT). EUR. HEART J. 37 (1), 67\u2013119 (2016).","journal-title":"EUR. HEART J."},{"issue":"4","key":"11066_CR3","doi-asserted-by":"publisher","first-page":"e12137","DOI":"10.1002\/pul2.12137","volume":"12","author":"PM Hendriks","year":"2022","unstructured":"Hendriks, P. M. et al. The evolution of survival of pulmonary arterial hypertension over 15 years. PULM CIRC. 12 (4), e12137 (2022).","journal-title":"PULM CIRC."},{"key":"11066_CR4","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3389\/fgene.2020.00782","volume":"11","author":"Q Li","year":"2020","unstructured":"Li, Q., Meng, L. & Liu, D. Screening and identification of therapeutic targets for pulmonary arterial hypertension through microarray technology. FRONT. GENET. 11, 782 (2020).","journal-title":"FRONT. GENET."},{"issue":"1","key":"11066_CR5","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1080\/21655979.2021.1936816","volume":"12","author":"Y Zeng","year":"2021","unstructured":"Zeng, Y. et al. Screening of key biomarkers and immune infiltration in pulmonary arterial hypertension via integrated bioinformatics analysis. BIOENGINEERED 12 (1), 2576\u20132591 (2021).","journal-title":"BIOENGINEERED"},{"issue":"2","key":"11066_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/2045893217701438","volume":"7","author":"O Boucherat","year":"2017","unstructured":"Boucherat, O. et al. The cancer theory of pulmonary arterial hypertension. PULM CIRC. 7 (2), 285\u2013299 (2017).","journal-title":"PULM CIRC."},{"key":"11066_CR7","doi-asserted-by":"crossref","unstructured":"Humbert, M. et al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. EUR. RESPIR J. 61(1). (2023).","DOI":"10.1183\/13993003.00879-2022"},{"issue":"1","key":"11066_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13167-015-0030-6","volume":"6","author":"G Grech","year":"2015","unstructured":"Grech, G. et al. EPMA position paper in cancer: current overview and future perspectives. EPMA J. 6 (1), 9 (2015).","journal-title":"EPMA J."},{"issue":"Suppl K","key":"11066_CR9","doi-asserted-by":"publisher","first-page":"K9","DOI":"10.1093\/eurheartj\/suz204","volume":"21","author":"DG Kiely","year":"2019","unstructured":"Kiely, D. G., Lawrie, A. & Humbert, M. Screening strategies for pulmonary arterial hypertension. EUR. HEART J. SUPPL. 21 (Suppl K), K9\u2013K20 (2019).","journal-title":"EUR. HEART J. SUPPL."},{"issue":"4","key":"11066_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/thx.2010.147272","volume":"66","author":"E Soon","year":"2011","unstructured":"Soon, E. et al. Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertension. THORAX 66 (4), 326\u2013332 (2011).","journal-title":"THORAX"},{"issue":"6","key":"11066_CR11","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1183\/09031936.00100510","volume":"37","author":"G Ruiter","year":"2011","unstructured":"Ruiter, G. et al. Iron deficiency is common in idiopathic pulmonary arterial hypertension. EUR. RESPIR J. 37 (6), 1386\u20131391 (2011).","journal-title":"EUR. RESPIR J."},{"issue":"7","key":"11066_CR12","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.7150\/thno.54113","volume":"11","author":"X Wu","year":"2021","unstructured":"Wu, X., Li, Y., Zhang, S. & Zhou, X. Ferroptosis as a novel therapeutic target for cardiovascular disease. THERANOSTICS 11 (7), 3052\u20133059 (2021).","journal-title":"THERANOSTICS"},{"key":"11066_CR13","doi-asserted-by":"publisher","first-page":"175093","DOI":"10.1016\/j.ejphar.2022.175093","volume":"928","author":"P Hu","year":"2022","unstructured":"Hu, P. et al. The mechanism of the imbalance between proliferation and ferroptosis in pulmonary artery smooth muscle cells based on the activation of SLC7A11. EUR. J. PHARMACOL. 928, 175093 (2022).","journal-title":"EUR. J. PHARMACOL."},{"key":"11066_CR14","doi-asserted-by":"publisher","first-page":"104471","DOI":"10.1016\/j.mvr.2022.104471","volume":"146","author":"J Liao","year":"2023","unstructured":"Liao, J. et al. PRDX6-mediated pulmonary artery endothelial cell ferroptosis contributes to monocrotaline-induced pulmonary hypertension. MICROVASC RES. 146, 104471 (2023).","journal-title":"MICROVASC RES."},{"issue":"1","key":"11066_CR15","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1038\/s41598-022-06848-7","volume":"12","author":"SS Xie","year":"2022","unstructured":"Xie, S. S. et al. Endothelial cell ferroptosis mediates monocrotaline-induced pulmonary hypertension in rats by modulating NLRP3 inflammasome activation. Sci. Rep. 12 (1), 3056 (2022).","journal-title":"Sci. Rep."},{"issue":"2","key":"11066_CR16","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/jcmm.16193","volume":"25","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension. J. CELL. MOL. MED. 25 (2), 1221\u20131237 (2021).","journal-title":"J. CELL. MOL. MED."},{"issue":"6","key":"11066_CR17","doi-asserted-by":"publisher","first-page":"7619","DOI":"10.3934\/mbe.2021377","volume":"18","author":"F Zhang","year":"2021","unstructured":"Zhang, F. & Liu, H. Identification of ferroptosis-associated genes exhibiting altered expression in pulmonary arterial hypertension. MATH. BIOSCI. ENG. 18 (6), 7619\u20137630 (2021).","journal-title":"MATH. BIOSCI. ENG."},{"issue":"1","key":"11066_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41420-023-01535-6","volume":"9","author":"E Wang","year":"2023","unstructured":"Wang, E., Zhou, S., Zeng, D. & Wang, R. Molecular regulation and therapeutic implications of cell death in pulmonary hypertension. Cell. Death Discov. 9 (1), 239 (2023).","journal-title":"Cell. Death Discov"},{"key":"11066_CR19","doi-asserted-by":"crossref","unstructured":"Zhou, N. & Bao, J. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database (Oxford). 2020. (2020).","DOI":"10.1093\/database\/baaa021"},{"issue":"1","key":"11066_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/21623945.2020.1795434","volume":"9","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Integrative analyses of biomarkers and pathways for adipose tissue after bariatric surgery. ADIPOCYTE 9 (1), 384\u2013400 (2020).","journal-title":"ADIPOCYTE"},{"issue":"D1","key":"11066_CR21","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","volume":"49","author":"SL Freshour","year":"2021","unstructured":"Freshour, S. L. et al. Integration of the Drug-Gene interaction database (DGIdb 4.0) with open crowdsource efforts. NUCLEIC ACIDS RES. 49 (D1), D1144\u2013D1151 (2021).","journal-title":"NUCLEIC ACIDS RES."},{"issue":"7","key":"11066_CR22","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. NUCLEIC ACIDS RES. 43 (7), e47 (2015).","journal-title":"NUCLEIC ACIDS RES."},{"key":"11066_CR23","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2147\/OTT.S294500","volume":"14","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Comprehensive analysis of gene expression changes and validation in hepatocellular carcinoma. Onco Targets Ther. 14, 1021\u20131031 (2021).","journal-title":"Onco Targets Ther."},{"key":"11066_CR24","doi-asserted-by":"publisher","first-page":"881914","DOI":"10.3389\/fimmu.2022.881914","volume":"13","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Diagnostic and predictive values of Ferroptosis-Related genes in child Sepsis. FRONT. IMMUNOL. 13, 881914 (2022).","journal-title":"FRONT. IMMUNOL."},{"issue":"D1","key":"11066_CR25","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. NUCLEIC ACIDS RES. 53 (D1), D672\u2013D677 (2025).","journal-title":"NUCLEIC ACIDS RES."},{"issue":"11","key":"11066_CR26","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. PROTEIN SCI. 28 (11), 1947\u20131951 (2019).","journal-title":"PROTEIN SCI."},{"key":"11066_CR27","doi-asserted-by":"publisher","first-page":"1104462","DOI":"10.3389\/fimmu.2022.1104462","volume":"13","author":"MN Wu","year":"2022","unstructured":"Wu, M. N. et al. Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis. FRONT. IMMUNOL. 13, 1104462 (2022).","journal-title":"FRONT. IMMUNOL."},{"issue":"8","key":"11066_CR28","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1111\/jcmm.17239","volume":"26","author":"X Wu","year":"2022","unstructured":"Wu, X. et al. Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from coronary artery disease. J. CELL. MOL. MED. 26 (8), 2177\u20132190 (2022).","journal-title":"J. CELL. MOL. MED."},{"key":"11066_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"issue":"5","key":"11066_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. NAT. METHODS. 12 (5), 453\u2013457 (2015).","journal-title":"NAT. METHODS"},{"key":"11066_CR31","doi-asserted-by":"crossref","unstructured":"Agarwal, V., Bell, G. W., Nam, J. W. & Bartel, D. P. Predicting Effective microRNA Target Sites in Mammalian mRNAs4 (ELIFE, 2015).","DOI":"10.7554\/eLife.05005"},{"issue":"D1","key":"11066_CR32","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen, Y. & Wang, X. MiRDB: an online database for prediction of functional MicroRNA targets. NUCLEIC ACIDS RES. 48 (D1), D127\u2013D131 (2020).","journal-title":"NUCLEIC ACIDS RES."},{"issue":"8","key":"11066_CR33","doi-asserted-by":"publisher","first-page":"R90","DOI":"10.1186\/gb-2010-11-8-r90","volume":"11","author":"D Betel","year":"2010","unstructured":"Betel, D., Koppal, A., Agius, P., Sander, C. & Leslie, C. Comprehensive modeling of MicroRNA targets predicts functional non-conserved and non-canonical sites. GENOME BIOL. 11 (8), R90 (2010).","journal-title":"GENOME BIOL."},{"issue":"W1","key":"11066_CR34","doi-asserted-by":"publisher","first-page":"W176","DOI":"10.1093\/nar\/gkw443","volume":"44","author":"P Furio-Tari","year":"2016","unstructured":"Furio-Tari, P., Tarazona, S., Gabaldon, T., Enright, A. J. & Conesa, A. SpongeScan: A web for detecting MicroRNA binding elements in LncRNA sequences. NUCLEIC ACIDS RES. 44 (W1), W176\u2013W180 (2016).","journal-title":"NUCLEIC ACIDS RES."},{"key":"11066_CR35","doi-asserted-by":"publisher","first-page":"624714","DOI":"10.3389\/fcvm.2021.624714","volume":"8","author":"H Zeng","year":"2021","unstructured":"Zeng, H., Liu, X. & Zhang, Y. Identification of potential biomarkers and immune infiltration characteristics in idiopathic pulmonary arterial hypertension using bioinformatics analysis. Front. Cardiovasc. Med. 8, 624714 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"11066_CR36","doi-asserted-by":"crossref","unstructured":"Chen, Y., Li, X., Wang, S., Miao, R. & Zhong, J. Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic Approaches in Cardiovascular Diseases. NUTRIENTS. 15(3). (2023).","DOI":"10.3390\/nu15030591"},{"key":"11066_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.freeradbiomed.2020.07.026","volume":"160","author":"T Bai","year":"2020","unstructured":"Bai, T., Li, M., Liu, Y., Qiao, Z. & Wang, Z. Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell. Free Radic Biol. Med. 160, 92\u2013102 (2020).","journal-title":"Free Radic Biol. Med."},{"issue":"4","key":"11066_CR38","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3892\/etm.2021.10599","volume":"22","author":"R Wang","year":"2021","unstructured":"Wang, R., Xu, J., Wu, J., Gao, S. & Wang, Z. Angiotensin-converting enzyme 2 alleviates pulmonary artery hypertension through Inhibition of focal adhesion kinase expression. EXP. THER. MED. 22 (4), 1165 (2021).","journal-title":"EXP. THER. MED."},{"issue":"7","key":"11066_CR39","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.rmed.2007.12.030","volume":"102","author":"Z Junhui","year":"2008","unstructured":"Junhui, Z. et al. Reduced number and activity of Circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension. Respir Med. 102 (7), 1073\u20131079 (2008).","journal-title":"Respir Med."},{"issue":"1","key":"11066_CR40","doi-asserted-by":"publisher","first-page":"14912","DOI":"10.1038\/s41598-021-94559-w","volume":"11","author":"NA Rashdan","year":"2021","unstructured":"Rashdan, N. A., Zhai, B. & Lovern, P. C. Fluid shear stress regulates placental growth factor expression via Heme Oxygenase 1 and iron. Sci. Rep. 11 (1), 14912 (2021).","journal-title":"Sci. Rep."},{"issue":"14","key":"11066_CR41","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jama.2022.4402","volume":"327","author":"NF Ruopp","year":"2022","unstructured":"Ruopp, N. F. & Cockrill, B. A. Diagnosis and treatment of pulmonary arterial hypertension: A review. JAMA 327 (14), 1379\u20131391 (2022).","journal-title":"JAMA"},{"issue":"1","key":"11066_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12265-023-10423-4","volume":"17","author":"J Song","year":"2024","unstructured":"Song, J. et al. Ferrostatin-1 blunts right ventricular hypertrophy and dysfunction in pulmonary arterial hypertension by suppressing the HMOX1\/GSH signaling. J. Cardiovasc. Transl Res. 17 (1), 183\u2013196 (2024).","journal-title":"J. Cardiovasc. Transl Res."},{"issue":"1","key":"11066_CR43","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s12872-023-03511-5","volume":"23","author":"J Lin","year":"2023","unstructured":"Lin, J., Lin, S., Zhang, Y. & Liu, W. Identification of Ferroptosis-related potential biomarkers and immunocyte characteristics in chronic thromboembolic pulmonary hypertension via bioinformatics analysis. BMC Cardiovasc. Disord. 23 (1), 504 (2023).","journal-title":"BMC Cardiovasc. Disord"},{"key":"11066_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.03.018","volume":"163","author":"MH Park","year":"2016","unstructured":"Park, M. H., Jo, M., Kim, Y. R., Lee, C. K. & Hong, J. T. Roles of Peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases. Pharmacol. Ther. 163, 1\u201323 (2016).","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"11066_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/ars.2017.7167","volume":"28","author":"SG Rhee","year":"2018","unstructured":"Rhee, S. G., Woo, H. A. & Kang, D. The role of Peroxiredoxins in the transduction of H(2)O(2) signals. Antioxid. Redox Signal. 28 (7), 537\u2013557 (2018).","journal-title":"Antioxid. Redox Signal."},{"issue":"7","key":"11066_CR46","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1089\/ars.2017.7214","volume":"28","author":"EA Veal","year":"2018","unstructured":"Veal, E. A., Underwood, Z. E., Tomalin, L. E., Morgan, B. A. & Pillay, C. S. Hyperoxidation of peroxiredoxins: gain or loss of function?? Antioxid. Redox Signal. 28 (7), 574\u2013590 (2018).","journal-title":"Antioxid. Redox Signal."},{"issue":"14","key":"11066_CR47","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1161\/CIRCULATIONAHA.105.582239","volume":"113","author":"S Matsushima","year":"2006","unstructured":"Matsushima, S. et al. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice. CIRCULATION 113 (14), 1779\u20131786 (2006).","journal-title":"CIRCULATION"},{"issue":"11","key":"11066_CR48","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1093\/abbs\/gmx102","volume":"49","author":"H Su","year":"2017","unstructured":"Su, H., Pistolozzi, M., Shi, X., Sun, X. & Tan, W. Alterations in NO\/ROS ratio and expression of Trx1 and Prdx2 in isoproterenol-induced cardiac hypertrophy. Acta Biochim. Biophys. Sin (Shanghai). 49 (11), 1022\u20131028 (2017).","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"key":"11066_CR49","doi-asserted-by":"publisher","first-page":"110357","DOI":"10.1016\/j.biopha.2020.110357","volume":"129","author":"C Tang","year":"2020","unstructured":"Tang, C. et al. Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis. BIOMED. PHARMACOTHER. 129, 110357 (2020).","journal-title":"BIOMED. PHARMACOTHER"},{"key":"11066_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neuro.2021.07.001","volume":"86","author":"MS McCann","year":"2021","unstructured":"McCann, M. S., Fernandez, H. R., Flowers, S. A. & Maguire-Zeiss, K. A. Polychlorinated biphenyls induce oxidative stress and metabolic responses in astrocytes. NEUROTOXICOLOGY 86, 59\u201368 (2021).","journal-title":"NEUROTOXICOLOGY"},{"key":"11066_CR51","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.ijbiomac.2018.02.009","volume":"112","author":"W Guo","year":"2018","unstructured":"Guo, W. et al. Prdx1 alleviates cardiomyocyte apoptosis through ROS-activated MAPK pathway during myocardial ischemia\/reperfusion injury. INT. J. BIOL. MACROMOL. 112, 608\u2013615 (2018).","journal-title":"INT. J. BIOL. MACROMOL."},{"issue":"6","key":"11066_CR52","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/CIRCRESAHA.108.174870","volume":"103","author":"J Kisucka","year":"2008","unstructured":"Kisucka, J. et al. Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis. CIRC. RES. 103 (6), 598\u2013605 (2008).","journal-title":"CIRC. RES."},{"key":"11066_CR53","doi-asserted-by":"crossref","unstructured":"Hu, Y., Chi, L., Kuebler, W. M. & Goldenberg, N. M. Perivascular inflammation in pulmonary arterial hypertension. CELLS-BASEL 9(11). (2020).","DOI":"10.3390\/cells9112338"},{"issue":"9","key":"11066_CR54","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/thx.2004.029082","volume":"60","author":"MC Tamby","year":"2005","unstructured":"Tamby, M. C. et al. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. THORAX 60 (9), 765\u2013772 (2005).","journal-title":"THORAX"},{"issue":"4","key":"11066_CR55","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1183\/09031936.06.00152705","volume":"28","author":"MC Tamby","year":"2006","unstructured":"Tamby, M. C. et al. Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension. EUR. RESPIR J. 28 (4), 799\u2013807 (2006).","journal-title":"EUR. RESPIR J."},{"issue":"1","key":"11066_CR56","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13075-020-02281-1","volume":"22","author":"Y Wu","year":"2020","unstructured":"Wu, Y., He, X., Huang, N., Yu, J. & Shao, B. A20: a master regulator of arthritis. ARTHRITIS RES. THER. 22 (1), 220 (2020).","journal-title":"ARTHRITIS RES. THER."},{"key":"11066_CR57","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.12659\/MSM.901700","volume":"23","author":"DQ Wu","year":"2017","unstructured":"Wu, D. Q., Wu, H. B., Zhang, M. & Wang, J. A. Effects of zinc finger protein A20 on lipopolysaccharide (LPS)-Induced pulmonary Inflammation\/Anti-Inflammatory mediators in an acute lung injury\/acute respiratory distress syndrome rat model. Med. Sci. Monit. 23, 3536\u20133545 (2017).","journal-title":"Med. Sci. Monit."},{"issue":"3","key":"11066_CR58","doi-asserted-by":"publisher","first-page":"L456","DOI":"10.1152\/ajplung.00335.2018","volume":"316","author":"G Momtazi","year":"2019","unstructured":"Momtazi, G., Lambrecht, B. N., Naranjo, J. R. & Schock, B. C. Regulators of A20 (TNFAIP3): new drug-able targets in inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 316 (3), L456\u2013L469 (2019).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"10","key":"11066_CR59","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/ncb3609","volume":"19","author":"JH Lee","year":"2017","unstructured":"Lee, J. H. et al. A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1. NAT. CELL. BIOL. 19 (10), 1260\u20131273 (2017).","journal-title":"NAT. CELL. BIOL."},{"issue":"1","key":"11066_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12640-017-9724-y","volume":"32","author":"S Perga","year":"2017","unstructured":"Perga, S. et al. A20 in multiple sclerosis and parkinson\u2019s disease: clue to a common dysregulation of Anti-Inflammatory pathways?? NEUROTOX. RES. 32 (1), 1\u20137 (2017).","journal-title":"NEUROTOX. RES."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11066-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11066-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11066-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T08:31:38Z","timestamp":1757233898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11066-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11066"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11066-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25187"}}